广发医药精选股票C(017480)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-2,050,385.39 |
45,202,134.08 |
43,996,569.75 |
-23,521,843.43 |
| 利息合计 |
14,426.87 |
65,584.22 |
50,754.57 |
182,334.57 |
| 其中:存款利息收入 |
8,311.12 |
28,255.55 |
19,359.07 |
80,789.59 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
6,115.75 |
37,328.67 |
31,395.50 |
101,544.98 |
| 投资收益合计 |
-3,115,693.05 |
37,775,804.18 |
23,655,713.24 |
-23,784,109.49 |
| 其中:股票投资收益 |
-3,304,845.09 |
37,162,249.74 |
23,138,484.83 |
-25,466,451.84 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
21,186.48 |
13,930.82 |
105,603.92 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
189,152.04 |
592,367.96 |
503,297.59 |
1,576,738.43 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
928,099.01 |
7,192,664.98 |
20,262,518.93 |
7,516.42 |
| 其他收入 |
122,781.78 |
168,080.70 |
27,583.01 |
72,415.07 |
| 费用 |
458,454.20 |
1,665,165.47 |
1,142,094.21 |
2,655,559.30 |
| 管理人报酬 |
325,263.54 |
1,217,585.30 |
844,544.29 |
2,001,294.93 |
| 基金托管费 |
54,210.56 |
202,930.96 |
140,757.41 |
333,549.11 |
| 销售服务费 |
40,750.01 |
119,129.48 |
73,439.95 |
157,184.09 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
38,229.92 |
125,519.55 |
83,352.56 |
163,530.99 |
| 利润总额 |
-2,508,839.59 |
43,536,968.61 |
42,854,475.54 |
-26,177,402.73 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年